Advanced Accelerator Applications SA (AAAP) Upgraded at Zacks Investment Research
Advanced Accelerator Applications SA (NASDAQ:AAAP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday. The firm currently has a $44.00 price target on the stock. Zacks Investment Research’s price objective points to a potential upside of 15.76% from the stock’s previous close.
According to Zacks, “Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The company, develops, produces and commercializes molecular nuclear medicine diagnostic and therapeutic products. Its products in clinical development include Lutathera, Somakit and Annexin V-128. The company’s commercial products include Gluscan /Gluscan 500/Barnascan(R), IASOflu(R), IASOdopa(R), IASOcholine(R), MIBITEC/Adamibi and Leukokit(R). It operates primarily in France, Italy, the United Kingdom, Spain, Portugal, Israel, Switzerland, Germany and Canada. Advanced Accelerator Applications S.A. is headquartered in Saint Genis Pouilly, France. “
Shares of Advanced Accelerator Applications SA (NASDAQ:AAAP) traded down 2.21% during midday trading on Tuesday, reaching $38.01. The company had a trading volume of 108,894 shares. Advanced Accelerator Applications SA has a one year low of $18.00 and a one year high of $39.66. The company has a 50 day moving average of $36.18 and a 200 day moving average of $32.85. The company’s market capitalization is $1.49 billion.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/11/advanced-accelerator-applications-sa-aaap-upgraded-at-zacks-investment-research-2.html
Advanced Accelerator Applications SA (NASDAQ:AAAP) last announced its quarterly earnings data on Wednesday, August 31st. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.05. Advanced Accelerator Applications SA had a negative return on equity of 8.50% and a negative net margin of 12.87%. Analysts predict that Advanced Accelerator Applications SA will post ($0.44) EPS for the current fiscal year.
Institutional investors have recently made changes to their positions in the stock. Scopia Capital Management LP raised its position in shares of Advanced Accelerator Applications SA by 16.4% in the first quarter. Scopia Capital Management LP now owns 1,044,512 shares of the company’s stock valued at $36,579,000 after buying an additional 146,825 shares during the period. Vivo Capital LLC bought a new position in Advanced Accelerator Applications SA during the first quarter worth approximately $15,962,000. Lazard Asset Management LLC bought a new position in Advanced Accelerator Applications SA during the first quarter worth approximately $276,000. Royce & Associates LP bought a new position in Advanced Accelerator Applications SA during the second quarter worth approximately $454,000. Finally, Alps Advisors Inc. raised its position in Advanced Accelerator Applications SA by 27.2% in the second quarter. Alps Advisors Inc. now owns 55,178 shares of the company’s stock worth $1,668,000 after buying an additional 11,796 shares during the last quarter. 16.28% of the stock is owned by institutional investors and hedge funds.
Advanced Accelerator Applications SA Company Profile
Advanced Accelerator Applications SA is a radiopharmaceutical company that develops, produces and sells molecular nuclear medicine (MNM), diagnostic and therapeutic products. The Company’s lead therapeutic candidate, Lutathera, is being developed for the treatment of midgut neuroendocrine tumors (NETs).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Advanced Accelerator Applications SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Applications SA and related companies with MarketBeat.com's FREE daily email newsletter.